DURATOCIN

This brand name is authorized in Canada, Ecuador, Hong Kong, New Zealand, Singapore

Active ingredients

The drug DURATOCIN contains one active pharmaceutical ingredient (API):

1 Carbetocin UNII 88TWF8015Y - CARBETOCIN

Carbetocin selectively binds to oxytocin receptors in the smooth muscle of the uterus, stimulates rhythmic contractions of the uterus, increases the frequency of existing contractions, and raises the tone of the uterus musculature. Read about Carbetocin

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
DURATOCIN Solution for injection	Health Products and Food Branch (CA)	MPI, CA: SPM

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
H01BB03	Carbetocin	H Systemic hormonal preparations, excl. Sex hormones and insulins → H01 Pituitary and hypothalamic hormones and analogues → H01B Posterior pituitary lobe hormones → H01BB Oxytocin and analogues
Discover more medicines within H01BB03

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: CA	Health Products and Food Branch	Identifier(s): 02231593, 02496526
Country: EC	Agencia Nacional de Regulación, Control y Vigilancia Sanitaria	Identifier(s): 3136-MEE-1217
Country: HK	Department of Health Drug Office	Identifier(s): 50670
Country: NZ	Medicines and Medical Devices Safety Authority	Identifier(s): 11156
Country: SG	Health Sciences Authority	Identifier(s): 12401P, 15173P